Hartaj Singh analyst

Currently out of the existing stock ratings of Hartaj Singh, 200 are a BUY (97.09%), 6 are a HOLD (2.91%).

Hartaj Singh

Work Performance Price Targets & Ratings Chart

Analyst Hartaj Singh, has had 45.65% of price targets met with an average potential upside of 34.32%, reached in 285 days on average. Previously, Hartaj Singh worked at OPPENHEIMER, BTIG.

Hartaj Singh has documented 394 price targets and ratings displayed on 36 stocks. The coverage was on Healthcare, Industrials, Consumer Defensive sectors.

Most recent stock forecast was given on VRTX, Vertex Pharmaceuticals at 05-May-2026.

Wall Street Analyst Hartaj Singh

Analyst best performing recommendations are on MRNA (MODERNA).
The best stock recommendation documented was for MRNA (MODERNA) on 4/15/2020. The price target of $43 was fulfilled within 2 days with a profit of $5.75 (15.44%), with a performance score of 77.18.

Average potential price target upside

ALXN Alexion Pharmaceuticals CATB Catabasis Pharmaceuticals GILD Gilead Sciences INO Inovio Pharmaceuticals MRNA Moderna REGN Regeneron Pharmaceuticals SBBP Strongbridge Biopharma plc SNSS Sunesis Pharmaceuticals UTHR United Therapeutics VIRX Viracta Therapeutics VRTX Vertex Pharmaceuticals SRPT Sarepta Therapeutics BMEA Biomea Fusion GANX Gain Therapeutics ATXS Astria Therapeutics CLLS Cellectis SA ICVX Icosavax OPT Opthea Ltd ORTX Orchard Therapeutics PLC TRDA Entrada Therapeutics ARQL ArQule CELG Celgene

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 28-Jul-2017

$205

5 years 6 months 16 days ago
(05-May-2021)

3/5 (60%)

$35.09 (20.65%)

938

Hold Since 03-May-2021

$173

$156

5 years 6 months 18 days ago
(03-May-2021)

18/29 (62.07%)

$2.73 (1.60%)

667

Buy Since 08-Feb-2018

$166

$179

5 years 9 months 17 days ago
(04-Feb-2021)

21/21 (100%)

$10.41 (6.69%)

711

Hold Since 04-Feb-2021

$190

$194

5 years 9 months 17 days ago
(04-Feb-2021)

13/15 (86.67%)

$34.41 (22.12%)

458

Buy Since 06-Sep-2019

$175

$165

5 years 9 months 17 days ago
(04-Feb-2021)

3/3 (100%)

$19.41 (12.48%)

397

Show more analysts

Stocks Hartaj Singh covered previously. Scores are shown for active stocks only.

ALLO Allogene Therapeutics EL Estee Lauder Companies ELOX Eloxx Pharmaceuticals FSTX FStar Therapeutics HARP Harpoon Therapeutics LIFE aTyr Pharma NBSE NeuBase Therapeutics ONCT Oncternal Therapeutics SPRB Spruce Biosciences

Please expand the browser size to see the chart

✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?